论文部分内容阅读
目的观察参附注射液对晚期肿瘤患者免疫球蛋白、补体及血液流变性的影响。方法将62例患者随机分为两组,治疗组31例予参附注射液,对照组31例予0.9%氯化钠注射液,观察两组治疗15d后免疫球蛋白、补体、血液流变学指标的变化。结果治疗组免疫球蛋白、补体水平较对照组增高(P<0.01),血液粘度降低(P<0.01)。结论参附注射液能调节晚期肿瘤患者的免疫球蛋白、补体水平,改善其血液流变性。
Objective To observe the effect of Shenfu injection on immunoglobulin, complement and hemorrheology in advanced cancer patients. Methods Sixty-two patients were randomly divided into two groups. The treatment group received 31 cases of Shenfu injection and the control group received 0.9% sodium chloride injection. The immunoglobulin, complement, hemorheology Changes in indicators. Results The levels of immunoglobulin and complement in the treatment group were higher than those in the control group (P <0.01), and the blood viscosity was decreased (P <0.01). Conclusion Shenfu injection can regulate the level of immunoglobulin and complement in advanced cancer patients and improve their hemorrheological properties.